Oral Antidiabetic Drugs Market by Drugs Class Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2 Diabetes mellitus - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global oral antidiabetic drug market is expected to reach USD 35.91 billion by 2022, growing at a CAGR of 10.2% between 2017 and 2022.

Request Brochure Request Discount

06-Jan-2017 | Number of pages: 110 | Report Code: ZMR-687 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oral antidiabetic drugs market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD billion). The study includes drivers and restraints of the oral antidiabetic drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oral antidiabetic drugs market on a global level.

In order to give the users a comprehensive view of the Oral antidiabetic drugs market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the oral antidiabetic drugs market has also been included. The study encompasses a market attractiveness analysis, wherein the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the oral antidiabetic drugs market by segmenting the market based on drugs class and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. The drugs class segmentation includes sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. The meglitinides class is further segmented into repaglinide and nateglinide. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., Canada, China, Japan, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global oral antidiabetic drugs market include Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck and Pfizer.

This report segments the global oral antidiabetic drugs Market as follows:

Global Oral Antidiabetic Drugs Market: Drugs Class Analysis

  • Sulfonylureas
    • Glimepiride
    •  Gliclazide
    •  Glyburide
    •  Others
  • Meglitinides
  • Repaglinide
  • Nateglinide
  • Biguanides
    • Metformin
    •  Others
  • Alpha-glucosidase inhibitors
    • Acarbose
    •  Voglibose
    •  Others
  • Others

Global Oral Antidiabetic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Blood Glucose Test Strips Market by Drug Technology (Channel Technology and Wicking Technology), By Sales Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3239 | Report Format:

The report covers forecast and analysis for the blood glucose test strips market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the blood gluc...Read More

Active Wound Care Market by Product Type (Synthetic Skin Grafts, Allograft, Xenografts, Amniotic Tissue Grafts, Collagen Dressings, and Growth Factors); by Wound Type (Surgical Wounds, Ulcers [Pressure Ulcers, Diabetic Foot Ulcers, Arterial Ulcers, and Venous Ulcers], and Other Wounds), and by End Users (In-Patient Facilities and Out-Patient Facilities): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3238 | Report Format:

The report covers forecast and analysis for the active wound care market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the active wound care market along wi...Read More

Macrolide Drugs Market by Drug Type (14-membered ring agents, 14-membered ring agents, 15-membered ring agents (Azalides), 16-membered ring agents, and Ketolides), By Distribution Channels (Hospital pharmacies, Clinics, Hospitals, Retail pharmacies, and Online pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3230 | Report Format:

The report covers forecast and analysis for the macrolide drugs market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the macrolide drugs market along...Read More

Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, and Others), By Drug Type (mAb, Immunomodulators, Hematopoietic Agents, G-CSF, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3228 | Report Format:

The report covers forecast and analysis for the oncology biosimilar market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the oncology biosimilar...Read More

Automation and Control System Market in Pharmaceutical and Biotech Industry: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3900.00 | Report Code: ZMR-3213 | Report Format:

Global Automation and Control System Market: Overview Automation basically means the use of various control systems for operating equipments like machinery, processes in factories, boilers and heat treating ovens, stabilization of ships, aircrafts and other applications and vehicles with minimal...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.